REGENXBIO Inc. (RGNX:NASDAQ) closed at $6.93 on October 16, 2026, down 3.28% on the day. The stock trades 57.2% below its 52-week high of $16.19 and 26.9% above its 52-week low of $5.46. Over the past year, it lost 41.0%. REGENXBIO Inc. is part of the Health Care sector (Biotechnology: Biological Products (No Diagnostic Substances)).
| 5D | 1M | 3M | 6M | 1Y |
|---|---|---|---|---|
| -10.88% | -15.70% | -32.90% | -26.87% | -40.96% |
In 252 trading sessions since October 16, 2025, RGNX closed higher on 128 days (51%). Its best day was March 9, 2026 (+20.00%) and its worst was May 14, 2026 (-37.80%). The stock moved 10% or more in a single session 16 times. It opened at least 5% above the previous day's high 2 times.
Regenxbio Inc is a biotechnology company. It is engaged in the development, commercialization and licensing of recombinant adeno-associated virus gene therapy.
Find more stocks like RGNX with the Spikes, Gaps, Breakouts and Performance Tracker scanners.
Based on end-of-day data. For information only, not investment advice.